A
ALLR
Allarity Therapeutics, Inc. Common Stock
$0.87
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Allarity Therapeutics, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.79
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.21
Nov 14
Posts
No posts about ALLR yet.
About Allarity Therapeutics, Inc. Common Stock
Allarity Therapeutics is a small US biotechnology company that develops cancer drugs. It has no approved products to sell, so it earns no meaningful revenue. It pays for its research by raising money from investors and hopes a drug succeeds in clinical trials, which are the human tests required before a drug can be sold.